首页> 美国卫生研究院文献>AAPS PharmSciTech >Preparation and Evaluation of Tubular Micelles of Pluronic Lecithin Organogel for Transdermal Delivery of Sumatriptan
【2h】

Preparation and Evaluation of Tubular Micelles of Pluronic Lecithin Organogel for Transdermal Delivery of Sumatriptan

机译:舒马曲坦透皮递送的Pluronic卵磷脂有机凝胶管状胶束的制备和评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present work focuses on the preparation and evaluation of lecithin organogel system of thermoreversible polymer pluronic F127, which would enhance the stability and absorption of sumatriptan succinate across the skin. Formulations were developed with and without co-surfactant (pluronic F127). The prepared organogels were evaluated for its appearance, organoleptic characteristics, and feel upon application, homogeneity, occlusivenes, washability, pH, viscosity, spreadability, gel transition temperature of formulations. The formulations were also evaluated for drug content, in vitro drug diffusion properties and skin irritation testing. In vivo evaluation of formulations was carried out by hot plate and writhing test method, and finally the optimized formulation was subjected to stability studies. The developed formulations were easily washable, smooth in feel, and showed no clogging which indicate superior texture of system. Formulation, containing pluronic showed greater spreadability and higher drug diffusion rate as compared to pluronic free organogel. Drug content of organogel formulations was in the range of 94–97%. The pH of the formulations was 6.48 ± 0.5 and 6.98 ± 0.1, reflecting no risk of skin irritation. Pluronic not only enhances the stability of organogel by increasing the viscosity (from 6,541 ± 234.76 to 7,826 ± 155.65 poise) but also increases the release of drug from 67.39 ± 1.53% to 74.21 ± 1.7%. The sumatriptan exhibits higher and long lasting antinociceptive effect as indicated by the persistent increase in reaction time in hot plate and inhibited abdominal contraction in acetic acid-induced writhing test (p < 0.05). The prepared optimized formulation was found to be stable without any significant changes at room temperature.
机译:目前的工作集中于热可逆聚合物普卢尼克F127的卵磷脂有机凝胶体系的制备和评估,该体系将增强舒马普坦琥珀酸酯在皮肤上的稳定性和吸收。在有和没有辅助表面活性剂(普流尼克F127)的情况下开发配方。评估所制备的有机凝胶的外观,感官特性和施用时的感觉,均匀性,闭塞性,可洗性,pH,粘度,铺展性,制剂的凝胶转变温度。还评估了制剂的药物含量,体外药物扩散特性和皮肤刺激性测试。通过热板和扭曲试验方法对制剂进行体内评估,最后对优化后的制剂进行稳定性研究。所开发的配方易于清洗,手感顺滑且无堵塞现象,表明系统具有优异的质地。与不含普鲁尼克的有机凝胶相比,含普鲁尼克的制剂显示出更大的可扩展性和更高的药物扩散速率。有机凝胶制剂的药物含量在94–97%的范围内。制剂的pH为6.48±0.5和6.98±0.1,无皮肤刺激性。 Pluronic不仅可以通过增加粘度(从6,541±234.76到7,826±155.65泊)来增强有机凝胶的稳定性,还可以将药物的释放量从67.39±1.53%增加到74.21±1.7%。舒马曲坦显示出更高而持久的抗伤害作用,如在热板上持续增加反应时间所显示,并在乙酸引起的扭体试验中抑制了腹部的收缩(p <0.05)。发现制备的优化制剂在室温下是稳定的,没有任何显着变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号